The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.
Click on the button below to create your account and get immediate access to thousands of articles.
SPH spends USD144mln, gets controlling stake in Techpool Bio-pharma
SPH announced Monday that it had inked deal with Takeda Pharma AG to buy 100 percent stake of latter’s wholly owned subsidiary Takeda Chromo Beteiligungs AG through its investment subsidiary in Hong Kong with 144 million U.S. dollars (915 million yuan).
May22,2018
If you have any questions, please enter them in the box below.
Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to silkroadweekly@xinhua.org and share your stories with more people.
Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.
